North American coral snake venom

North American coral snake venom is a complex biological mixture produced by elapid snakes of the genus Micrurus, primarily the Eastern coral snake (Micrurus fulvius) and the Texas coral snake (Micrurus tener) (StatPearls, 2023). The venom is characterized by a high concentration of neurotoxic proteins, including three-finger toxins (3FTx) and phospholipases A2 (PLA2), which exhibit potent activity against the peripheral nervous system (Vergara et al., 2014). Its primary mechanism of toxicity involves the competitive and often irreversible blockade of post-synaptic nicotinic acetylcholine receptors at the neuromuscular junction, leading to progressive paralysis and potentially fatal respiratory failure (NIH, 2022). Unlike the venom of North American pit vipers, coral snake venom typically causes minimal local tissue damage or pain at the bite site, which can lead to a dangerous delay in medical evaluation (StatPearls, 2023). The only specific treatment is the administration of Antivenin (Micrurus fulvius), an equine-derived product that contains antibodies designed to bind and neutralize the venom's toxic components (FDA, 2021). Due to the risk of rapid clinical deterioration, patients suspected of envenomation require prolonged observation in an intensive care setting, even if they are initially asymptomatic (StatPearls, 2023).

Other names

Micrurus fulvius venomMicrurus tener venomEastern coral snake venomTexas coral snake venomMicrurus euryxanthus venom

Passive immunization through the administration of equine-derived antibodies that bind to and neutralize venom components, specifically three-finger toxins and phospholipases A2, thereby preventing their interaction with host nicotinic acetylcholine receptors (FDA, 2021).